Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer

NCT05943041 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Colorectal Cancer
Sigmoid Colon Cancer
Rectosigmoid Junction Cancer
Cancer
Rectal Cancer

Interventions

DRUG: GB104(Level 1)
DRUG: GB104(Level 2)
DRUG: GB104(Level 3)

Sponsor

GILongevity